Skip to NavigationSkip to content

Top Ten most popular articles on Pharmafile.com this week

Published on 14/08/20 at 10:10am

The top 10 news stories this week once again focus on coronavirus treatments and vaccines, as President Putin announced that Russia has granted regulatory approval for a COVID-19 vaccine while researchers at the University of Oxford have said that hydroxychloroquine could be beneficial to coronavirus patients, despite a general lack of evidence for its effectiveness.

In other news, Genentech’s Evrysdi (risdiplam) has secured FDA approval for the treatment of spinal muscular atrophy and Bristol Myers Squibb has announced positive data from two Phase 3 clinical trials of its drug Opdivo.

1. AstraZeneca seals manufacturing deal to deliver COVID-19 vaccine in China

1. AstraZeneca seals manufacturing deal to deliver COVID-19 vaccine in ChinaAstraZeneca has signed its first deal in China to produce and deliver its vaccine candidate against COVID-19 in the country, partnering up with manufacturing firm Shenzhen Kangtai Biological Products.1. AstraZeneca seals manufacturing deal to deliver COVID-19 vaccine in China

AstraZeneca has signed its first deal in China to produce and deliver its vaccine candidate against COVID-19 in the country, partnering up with manufacturing firm Shenzhen Kangtai Biological Products.

2. Researchers at the University of Oxford have said hydroxychloroquine could still be a viable COVID-19 treatment

Researchers at the University of Oxford have said that hydroxychloroquine could be beneficial to COVID-19 patients, despite a general lack of evidence for its effectiveness.

3. Coronavirus fake news has led to hundreds of deaths, according to a new study

At least 800 people have died around the world from COVID-19 misinformation in the first three months of 2020, according to researchers.

4. Russia becomes world’s first country to grant regulatory approval for a coronavirus vaccine

President Putin has announced that Russia is the first country to grant regulatory approval for a COVID-19 vaccine.

5. Over 100 Americans have died after taking hydroxychloroquine in the first half of 2020

More than 100 Americans have died after taking the drug hydroxychloroquine to treat or prevent coronavirus.

6. Over a third of Americans say they won’t take a coronavirus vaccine

35% of Americans say they have no plans to take a COVID-19 vaccine, according to new polling.

7. AstraZeneca's Fasenra has strong Phase 3 showing in severe eosinophilic asthma

AstraZeneca took the opportunity at the American Thoracic Society 2020 Virtual International Conference to unveil positive new Phase 3b data on the efficacy of Fasenra (benralizumab) in the treatment of severe eosinophilic asthma.

8. Arthritis drug Abatacept could be used to treat type 1 diabetes

People with type 1 diabetes could see their lives extended by the arthritis drug Abatacept, new study finds.

9. Genentech's Evrysdi becomes first FDA-approved oral treatment for spinal muscular atrophy

Genentech’s Evrysdi (risdiplam) has secured FDA approval for the treatment of spinal muscular atrophy (SMA), making it the first oral therapy available for the rare hereditary genetic condition in US and the third overall to be approved for the disease.

10. Bristol Myers Squibb announces positive results from Opdivo clinical trials

Bristol Myers Squibb has announced positive data from two Phase 3 clinical trials of its drug Opdivo.

Conor Kavanagh

Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches